The report highlights that, TCS is fortifying its capabilities in the med-tech space, and its business transformation capabilities, providing an end-to-end automated, agile, and Intelligent Business 4.0 framework; end-to-end business operations ownership; value-based consulting; and a cross-business CXO-level focus. It goes on to say TCS has been recognized for the strategic direction that it brings to its large clinical transformation programs, providing advisory services for regulatory and clinical IT landscape transformation, R&D business capabilities mapping, R&D long-range planning, and portfolio simplification and its expertise in everything related to data.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
